Biomarker Test Can Detect Alzheimer’s Earlier
A biomarker test can detect early-stage tau protein clumping associated with Alzheimer’s disease up to a decade before tau tangles appear.
Read MorePosted by Chris Wolski | Feb 10, 2025 | Dementias & Alzheimer’s |
A biomarker test can detect early-stage tau protein clumping associated with Alzheimer’s disease up to a decade before tau tangles appear.
Read MorePosted by Chris Wolski | Feb 6, 2025 | Lung Cancer |
Scientists have developed a low-cost, fast-response sensor capable of detecting lung cancer biomarkers from a blood sample in just 40 minutes.
Read MorePosted by Chris Wolski | Feb 6, 2025 | Diagnostic Technologies |
Researchers have developed a way to detect inflammation through antibodies, potentially enabling blood tests for disease-specific biomarkers.
Read MorePosted by Chris Wolski | Feb 6, 2025 | Urinalysis & Toxicology |
Higher PVSA compliance rates lead to better clinical outcomes, enhancing the laboratory’s reputation and value to healthcare providers.
Read MorePosted by Chris Wolski | Feb 4, 2025 | Breast |
Roche’s PATHWAY anti-HER2/neu (4B5) test has received FDA approval to ID patients with HR-positive, HER2-ultralow metastatic breast cancer.
Read More